Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 20367498)

Published in Stem Cells Dev on August 12, 2010

Authors

Henk Rozemuller1, Henk-Jan Prins, Benno Naaijkens, Jojet Staal, Hans-Jörg Bühring, Anton C Martens

Author Affiliations

1: Department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

Articles citing this

Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int (2012) 1.59

Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med (2012) 1.08

BMP12 induces tenogenic differentiation of adipose-derived stromal cells. PLoS One (2013) 1.00

Immunomodulation by mesenchymal stem cells in veterinary species. Comp Med (2013) 0.93

Isolation and characterisation of mesenchymal stem/stromal cells in the ovine endometrium. PLoS One (2015) 0.82

Mesenchymal stem-cell potential in cartilage repair: an update. J Cell Mol Med (2014) 0.80

Endometrial mesenchymal stem cells as a cell based therapy for pelvic organ prolapse. World J Stem Cells (2016) 0.80

Identification and Characterization of Human Endometrial Mesenchymal Stem/Stromal Cells and Their Potential for Cellular Therapy. Stem Cells Transl Med (2016) 0.79

In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors. BMC Cancer (2015) 0.79

Multiple Functions of MSCA-1/TNAP in Adult Mesenchymal Progenitor/Stromal Cells. Stem Cells Int (2015) 0.76

Comparative study of equine mesenchymal stem cells from healthy and injured synovial tissues: an in vitro assessment. Stem Cell Res Ther (2016) 0.75

Phenotypical and functional characteristics of mesenchymal stem cells derived from equine umbilical cord blood. Cytotechnology (2014) 0.75

Expression of neural cell adhesion molecule and polysialic acid in human bone marrow-derived mesenchymal stromal cells. Stem Cell Res Ther (2016) 0.75

Ovine Mesenchymal Stromal Cells: Morphologic, Phenotypic and Functional Characterization for Osteochondral Tissue Engineering. PLoS One (2017) 0.75

Limbal stromal cells derived from porcine tissue demonstrate mesenchymal characteristics in vitro. Sci Rep (2017) 0.75

Articles by these authors

Retracted Generation of pluripotent stem cells from adult human testis. Nature (2008) 5.49

Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells (2007) 3.39

Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica (2003) 2.17

Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica (2008) 1.80

Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration. J Biol Chem (2002) 1.63

Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell (2011) 1.62

MICA/NKG2D-mediated immunogene therapy of experimental gliomas. Cancer Res (2003) 1.60

Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation (2006) 1.59

Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J Allergy Clin Immunol (2002) 1.47

Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology. Stem Cells (2007) 1.39

Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol (2003) 1.28

Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources. Tissue Eng Part A (2012) 1.27

CD molecules 2006--human cell differentiation molecules. J Immunol Methods (2006) 1.23

Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. Cell Res (2005) 1.21

Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cells. FEBS Lett (2007) 1.16

Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma. Blood (2012) 1.15

Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation (2007) 1.15

Inhibitory effect of imatinib on normal progenitor cells in vitro. Blood (2003) 1.13

Biofabrication of osteochondral tissue equivalents by printing topologically defined, cell-laden hydrogel scaffolds. Tissue Eng Part C Methods (2011) 1.10

A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplant (2012) 1.10

Role of the CD47-SHPS-1 system in regulation of cell migration. EMBO J (2003) 1.10

The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress. Acta Neuropathol (2012) 1.10

The mesenchymal stem cell antigen MSCA-1 is identical to tissue non-specific alkaline phosphatase. Stem Cells Dev (2010) 1.09

Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients. Int Arch Allergy Immunol (2002) 1.02

Expression profile of the embryonic markers nanog, OCT-4, SSEA-1, SSEA-4, and frizzled-9 receptor in human periodontal ligament mesenchymal stem cells. J Cell Physiol (2010) 1.00

Prospective isolation of human MSC. Best Pract Res Clin Haematol (2011) 1.00

Decreased CD90 expression in human mesenchymal stem cells by applying mechanical stimulation. Head Face Med (2006) 0.99

High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors. Eur J Immunol (2005) 0.98

Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. Blood (2002) 0.98

A P19Cl6 GFP reporter line to quantify cardiomyocyte differentiation of stem cells. Int J Dev Biol (2004) 0.97

Accessory cells of the microenvironment protect multiple myeloma from T-cell cytotoxicity through cell adhesion-mediated immune resistance. Clin Cancer Res (2013) 0.96

Luciferase labeling for multipotent stromal cell tracking in spinal fusion versus ectopic bone tissue engineering in mice and rats. Tissue Eng Part A (2010) 0.95

Trifluorothymidine resistance is associated with decreased thymidine kinase and equilibrative nucleoside transporter expression or increased secretory phospholipase A2. Mol Cancer Ther (2010) 0.95

Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein. Cancer Immunol Immunother (2007) 0.95

Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres. J Immunol (2003) 0.95

Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets. Ann N Y Acad Sci (2012) 0.94

Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells. Stem Cells Dev (2011) 0.93

Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47. J Mol Biol (2006) 0.92

A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect. Haematologica (2008) 0.92

Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells. Cancer Immunol Immunother (2007) 0.91

MSCA-1/TNAP selection of human jaw periosteal cells improves their mineralization capacity. Cell Physiol Biochem (2011) 0.90

A nomenclature for signal regulatory protein family members. J Immunol (2005) 0.90

Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2. Stem Cells Dev (2013) 0.90

Human regulatory T cells do not suppress the antitumor immunity in the bone marrow: a role for bone marrow stromal cells in neutralizing regulatory T cells. Clin Cancer Res (2013) 0.89

Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease. Mov Disord (2013) 0.89

The impact of cell source, culture methodology, culture location, and individual donors on gene expression profiles of bone marrow-derived and adipose-derived stromal cells. Stem Cells Dev (2012) 0.89

A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures. Stem Cells (2008) 0.89

Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells. J Immunol (2013) 0.89

Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha. J Immunol (2004) 0.88

LNGFR induction during osteogenesis of human jaw periosteum-derived cells. Cell Physiol Biochem (2009) 0.88

Detection of novel CD antigens on the surface of human mast cells and basophils. Int Arch Allergy Immunol (2002) 0.87

SIRPbeta1 is expressed as a disulfide-linked homodimer in leukocytes and positively regulates neutrophil transepithelial migration. J Biol Chem (2005) 0.87

Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis. J Rheumatol (2005) 0.87

Infection-induced bystander-apoptosis of monocytes is TNF-alpha-mediated. PLoS One (2013) 0.87

Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells--potential and pitfalls. Adv Drug Deliv Rev (2010) 0.86

HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis. Haematologica (2010) 0.86

Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer. Cancer Immunol Immunother (2013) 0.85

Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line. Eur J Immunol (2003) 0.85

Non-invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo. Cell Microbiol (2009) 0.85

Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo. PLoS Pathog (2010) 0.85

Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions. J Mol Med (Berl) (2010) 0.84

Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas. Stem Cells Transl Med (2012) 0.83

Assays for measuring in vitro basophil activation induced by recombinant allergens. Methods (2004) 0.82

Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET. J Biol Chem (2014) 0.82

Eradication of medullary multiple myeloma by CD4+ cytotoxic human T lymphocytes directed at a single minor histocompatibility antigen. Clin Cancer Res (2010) 0.81

In vitro and in vivo angiogenic capacity of BM-MSCs/HUVECs and AT-MSCs/HUVECs cocultures. Biofabrication (2014) 0.81

The European Competence Network on Mastocytosis (ECNM). Wien Klin Wochenschr (2004) 0.81

Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction. Blood (2005) 0.80

Human maxillary sinus floor elevation as a model for bone regeneration enabling the application of one-step surgical procedures. Tissue Eng Part B Rev (2012) 0.79

Binding affinity and capacity of putative adaptor-mediated sorting of a Type I membrane protein in Leishmania mexicana. Mol Biochem Parasitol (2005) 0.78

Adipose tissue-derived mesenchymal stem cells as monocultures or cocultures with human umbilical vein endothelial cells: performance in vitro and in rat cranial defects. J Biomed Mater Res A (2013) 0.78

Clonal heterogeneity in growth kinetics of CD34+CD38- human cord blood cells in vitro is correlated with gene expression pattern and telomere length. Stem Cells (2005) 0.78

Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate. Prostate (2013) 0.78

Update on canine MSC markers. Cytometry A (2014) 0.78

A novel approach revealing the effect of a collagenous membrane on osteoconduction in maxillary sinus floor elevation with β-tricalcium phosphate. Eur Cell Mater (2013) 0.78

Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3. J Leukoc Biol (2003) 0.78

Isolation of adult human spermatogonial progenitors using novel markers. J Mol Cell Biol (2013) 0.77

In vivo matrix production by bone marrow stromal cells seeded on PLGA scaffolds for ligament tissue engineering. Tissue Eng Part A (2009) 0.77

Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients: Protocol Optimization and Therapeutic Potential. J Immunother (2016) 0.76

Brief report: Autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the Teff cell compartment. Arthritis Rheumatol (2014) 0.75

Correlation of high-resolution X-ray micro-computed tomography with bioluminescence imaging of multiple myeloma growth in a xenograft mouse model. Calcif Tissue Int (2009) 0.75

Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases. Prostate (2012) 0.75

Histological assessment of the sclerotic graft-versus-host response in the humanized RAG2-/-γc-/- mouse model. Biol Blood Marrow Transplant (2012) 0.75

Bone forming capacity of cell- and growth factor-based constructs at different ectopic implantation sites. J Biomed Mater Res A (2014) 0.75

Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1. J Leukoc Biol (2005) 0.75